| Assessment Status | Full HTA Assessment |
| HTA ID | - |
| Drug | Melatonin |
| Brand | Circadin® |
| Indication | Prolonged release melatonin (Circadin®) for the short-term treatment of primary insomnia. |
| Assessment Process | |
| Full submission received from Applicant | 01/08/2008 |
| NCPE assessment completed | 21/10/2008 |
| NCPE assessment outcome | Reimbursement not recommended. |
We believe that there is currently insufficient evidence to support the reimbursement of this product under the Community Drugs Schemes.